(Q40397313)

English

Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats

scientific article published on September 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ran-Yi Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Li-Zhi Wu

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Bi-Jun Huang

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Jia-Ling Huang

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Yan-Ling Zhang

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Miao-La Ke

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Jun-Mei Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Wei-Ping Tan

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Ru-Hua Zhang

9

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Han-Kui Chen

10

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Yi-Xin Zeng

11

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Wenlin Huang

12

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

112

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

24-31

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Severe acute respiratory syndrome (SARS)--paradigm of an emerging viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Synthetic peptide studies on the severe acute respiratory syndrome (SARS) coronavirus spike glycoprotein: perspective for SARS vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Localization of antigenic sites of the E2 glycoprotein of transmissible gastroenteritis coronavirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Four major antigenic sites of the coronavirus transmissible gastroenteritis virus are located on the amino-terminal half of spike glycoprotein S

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Effects of a SARS-associated coronavirus vaccine in monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

SARS corona virus peptides recognized by antibodies in the sera of convalescent cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Identification of two antigenic epitopes on SARS-CoV spike protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Th2 predominance and CD8+ memory T cell depletion in patients with severe acute respiratory syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

A semi-empirical method for prediction of antigenic determinants on protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Profile of specific antibodies to the SARS-associated coronavirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Medicine. Caution urged on SARS vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

ProPred: prediction of HLA-DR binding sites.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Induction of protective immunity in chickens vaccinated with infectious bronchitis virus S1 glycoprotein expressed by a recombinant baculovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Induction of mucosal immunity with a replication-defective adenoviral recombinant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Immunogenicity of SARS inactivated vaccine in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.02.009

7 January 2021

Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method

1 reference

https://pubmed.ncbi.nlm.nih.gov/16022898

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acrylamide in food

1 reference

https://pubmed.ncbi.nlm.nih.gov/16022898

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of subgroups of peripheral blood T lymphocytes in patients with severe acute respiratory syndrome and its clinical significance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16022898

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe acute respiratory syndrome spreads worldwide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16022898

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VIRUSRES.2005.02.009

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40397313&oldid=1896906428"